title: Droperidol--behind the black box warning.
authors.affiliation: Oregon Health & Science University, Portland, OR, USA. horowiza@ohsu.edu
authors.forename: B Zane
authors.initials: BZ
authors.lastname: Horowitz
authors.forename: Kenneth
authors.initials: K
authors.lastname: Bizovi
authors.forename: Raymond
authors.initials: R
authors.lastname: Moreno
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000932:Antiemetics / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004329:Droperidol / Q000009:adverse effects*; D004348:Drug Labeling; D004635:Emergency Medicine / Q000379:methods; D005060:Europe; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000401:mortality; D009325:Nausea / Q000188:drug therapy; D016171:Torsades de Pointes / Q000139:chemically induced* / Q000401:mortality; D014481:United States; D014486:United States Food and Drug Administration; D014839:Vomiting / Q000188:drug therapy
chemical_list: D000932:Antiemetics; D004329:Droperidol